Chandra Bhagat Pharma Ltd.
Snapshot View

View in App

Prices View details >>

96.30 ▼0%

21 March 2023, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.cbcpharma.com
Market Cap 72.66 Cr.
Enterprise Value(EV) 88.03 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.06 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 91.20 Trailing Twelve Months Ending 2022-03
Industry PE 32.00 Trailing Twelve Months Ending 2022-03
Book Value / Share 33.68 Trailing Twelve Months Ending 2022-03
Price to Book Value 2.86 Calculated using Price: 96.30
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.75 Cr. 7,545,056 Shares
FaceValue 10
Company Profile
The company is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. It provides pharmaceuticals and special chemical products in the Indian and international market. It has wide range of products portfolio of pharmaceutical formulation including IV & IM range Injections, few tablets to cater the Domestic & Export Market.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
1 Month
-12.45%
3 Month
-14.78%
6 Month
-9.36%
1 Year
-7.54%
2 Year
+143.18%
5 Year
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 7.53 6.89 5.38 9.33 13.44 6.46 1.67 0.78 3.19
Return on Capital Employed (%) 11.66 10.40 12.62 14.34 17.58 13.40 7.16 7.63 8.83
Return on Assets (%) 1.27 1.16 0.82 1.32 1.82 0.98 0.40 0.26 1.10

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 3 6 6 7 7 8 14 26 26 27
Non Curr. Liab. 0 0 0 0 11 21 16 15 13 8
Curr. Liab. 21 26 36 38 37 29 53 34 33 38
Minority Int.
Equity & Liab. 24 32 42 44 56 58 83 75 72 72
Non Curr. Assets 1 1 1 1 1 1 0 0 0 0
Curr. Assets 23 31 41 44 55 57 81 73 70 71
Misc. Exp. not W/O 0 1 1 1 1
Total Assets 24 32 42 44 56 58 83 75 72 72

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 35 48 61 80 90 97 106 94 71 94
Other Income 1 0 0 0 1 0 0 0 2
Total Income 35 49 61 80 90 98 107 94 71 96
Total Expenditure -35 -46 -58 -76 -85 -92 -102 -91 -67 -91
PBIDT 0 2 3 5 5 5 5 4 4 4
Interest -2 -2 -4 -4 -4 -4 -3 -4 -3
Depreciation 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 -1 0 0 0 0
Exceptional Items
PAT 0 0 0 0 1 1 1 0 0 1
Adjusted EPS 9 8 10 8 2 3 1 0 0 1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -9 -6 4 -7 8 12
Cash Fr. Inv. 0 0 0 0 0 0
Cash Fr. Finan. 8 7 -4 7 -6 -10
Net Change -1 0 0 0 2 3
Cash & Cash Eqvt 1 1 0 0 3 6

Shareholding Pattern View Details >>

6 Qtrs 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%) 2022-09 (%)
Promoter 70.42 70.42 71.80 71.80 70.11 69.09
Public 29.58 29.58 28.20 28.20 29.89 30.91
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 14 Nov 2022
Approval Of Un-Audited Financial Result As On 30Th September 2022.
Approval of Un-Audited Financial Result as on 30th September 2022.
Mon, 14 Nov 2022
Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th November 2022 For Approval Of Un-Audited Financial Result As On 30Th September 2022.
Outcome of Board Meeting held on 14th November 2022 for approval of Un-Audited Financial Result as on 30th September 2022.
Mon, 07 Nov 2022
Board Meeting Intimation for Approval Of Un-Audited Financial Result As On 30.09.2022.
Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Un-Audited Financial Result as on 30.09.2022 and any other Business.

Technical Scans View Details >>

Tue, 21 Mar 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at Low Opening at Low
Closing Below Previous Low Closing Below Previous Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,142.55 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 75,408.82 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,473.23 2,818.70 +0.5%
Cipla Ltd. 71,800.08 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,246.53 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,239.05 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,031.17 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.01 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.72 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.07 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.21 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.27 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.79 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.27 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.43 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.07 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.84 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Chandra Bhagat Pharma Ltd.

What is Chandra Bhagat Pharm share price?
Can I buy Chandra Bhagat Pharm shares now?
What is the Market Cap of Chandra Bhagat Pharm?
What are the key metrics to analyse Chandra Bhagat Pharm?
What is the 52 Week High and Low of Chandra Bhagat Pharm?